Significantly Higher Levels of Vascular Endothelial Growth Factor (VEGF) and Shorter Survival Times for Patients With Primary Operable Triple-Negative Breast Cancer

Ann Oncol. 2009 Oct 1;20(10):1639-1646, BK Linderholm, H Hellborg, U Johansson, G Elmberger, L Skoog, J Lehtiö, R Lewensohn

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

Triple-negative breast cancer (TBNC), which lacks expression of estrogen receptors (ER) and progesterone receptors (PR), as well as of human epidermal growth factor receptor 2 (HER2), is associated with much poorer prognosis than are other types of breast cancer. Increased expression of another growth factor receptor, vascular endothelial growth factor (VEGF), has been associated with poor prognosis in breast cancer and other types of cancer. This study evaluated the relationships between VEGF levels...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration